<DOC>
	<DOCNO>NCT01642511</DOCNO>
	<brief_summary>In addition axillary lymph node , internal mammary lymph node ( IMLN ) chain also first-echelon nodal drainage site metastasis provide important prognostic information breast cancer patient . The internal mammary sentinel lymph node biopsy ( IM-SLNB ) provide less invasive method assess IMLN surgical dissection . But low visualization rate IMSLN restriction IM-SLNB . This clinical trial carry improve visualization rate IMSLN modify technique : ( 1 ) The radiotracer inject intraparenchymally 2~4 quadrant breast . ( 2 ) The radiotracer inject high volume . ( 3 ) The radiotracer inject ultrasonographic guidance .</brief_summary>
	<brief_title>Internal Mammary Sentinel Lymph Node Biopsy Early Breast Cancer Patients With Clinically Axillary Node -Negative</brief_title>
	<detailed_description>OBJECTIVES : - Compare visualization rate internal mammary sentinel lymph node breast cancer patient different injection technology . - Evaluate metastasis rate internal mammary sentinel lymph nodes patient clinically axillary node -negative patient . - Evaluate risk factor internal mammary sentinel lymph node metastasis - Evaluate success rate safety internal mammary sentinel lymph node biopsy . - Draw learn curve internal mammary sentinel lymph node biopsy . OUTLINE : 3~18 hour surgery , 99mTc-labeled sulfur colloid inject ultrasonographic guidance different pattern injection method classify accord number injection quadrant . Subsequently , lymphoscintigraphy perform 0.5~1.0 hour surgery . During surgery , sentinel lymph node ( axillary internal mammary ) identify combine use intraoperative gamma detector blue dye . The sentinel lymph node ( axillary internal mammary ) analyze hematoxylin-eosin staining immunohistochemistry future therapy planning .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>primary breast cancer clinically axillanegative enlarge internal mammary node image</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Sentinel Lymph Node Biopsy</keyword>
	<keyword>Internal Mammary</keyword>
	<keyword>Lymphoscintigraphy</keyword>
</DOC>